3 Downloads (Pure)

Abstract

Adverse outcome pathways are tools to capture and visualize mechanisms underlying adverse effects, and are currently emerging in the areas of toxicology and chemical risk assessment. Less attention has yet been paid to potential clinical applications of adverse outcome pathways, including in the hepatology field. Liver adverse outcome pathways can serve the development and optimization of the clinically relevant animal models of liver diseases for fundamental and translational research as well as for testing new liver therapeutics. They also can aid the characterization of novel and more specific diagnostic and prognostic biomarkers of liver disease. Full clinical exploitation in these directions requires further technical optimization of adverse outcome pathways as well as intensive interdisciplinary and intersectoral collaboration.
Original languageEnglish
Pages (from-to)659-664
Number of pages6
JournalJournal of Gastrointestinal and Liver Diseases
Volume29
Issue number4
DOIs
Publication statusPublished - 27 Oct 2020

Fingerprint Dive into the research topics of 'Liver adverse outcome pathways: what's in for the hepatologist?'. Together they form a unique fingerprint.

Cite this